m+Medelevator.RU
← Поиск публикаций
Frontiers in endocrinology · 2026

Beyond HbA1c: insulin resistance as a modifier of early vascular injury in adolescents with type 1 diabetes.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Yoon Jungin, Kim Jiyul, Park Seongjun, Kim Woojae

Аннотация

Type 1 diabetes (T1D), which commonly presents in childhood or adolescence, is an autoimmune disease in which immune-mediated destruction of pancreatic β-cells leads to absolute or near-absolute insulin deficiency and lifelong dependence on insulin administration. During adolescence, pubertal changes and increased insulin requirements can worsen glycemic instability and raise the risk of vascular complications, such as cardiovascular disease. Although hyperglycemia promotes vascular injury, different early vascular phenotypes in adolescents with similar hemoglobin A1c (HbA1c) levels suggest that additional mechanisms may influence vascular risk. Insulin resistance (IR) may be an important contributor because insulin sensitivity declines during puberty, and this decline is associated with oxidative stress, altered endothelial signaling, inflammation, and adiposity. However, establishing a causal relationship between IR and early vascular injury in T1D remains challenging. This review examines the link between IR and early vascular injury in adolescents with T1D and emphasizes endothelial dysfunction, arterial stiffness, and biomarkers that may connect metabolic stress to vascular damage. Evidence from metabolic, endothelial, inflammatory, omics-based, and imaging studies supports an association between IR, inflammatory pathways, endothelial injury, and impaired vascular repair. Overall, IR, inflammatory, endothelial, and vascular imaging measures may complement HbA1c when studying vascular risk in adolescents with T1D. Whether they provide additional diagnostic or prognostic value beyond HbA1c is still unknown.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты